These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19449746)

  • 1. [Costs of type II diabetes in the conditions of the Czech Republic's medical care system].
    Dolezal T; Písaríková Z; Zemanová P; Bartásková D
    Vnitr Lek; 2009 Apr; 55(4):342-4. PubMed ID: 19449746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of self-measurement of blood glucose on complications of type 2 diabetes: economic analysis from a Czech perspective.
    Weber C; Kocher S; Neeser K; Bartaskova D
    Curr Med Res Opin; 2010 Feb; 26(2):289-96. PubMed ID: 19947908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revealing the cost of Type II diabetes in Europe.
    Jönsson B;
    Diabetologia; 2002 Jul; 45(7):S5-12. PubMed ID: 12136405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacoeconomy of diabetes mellitus--trends in the Czech Republic].
    Horák P
    Vnitr Lek; 2009 Apr; 55(4):331-40. PubMed ID: 19449745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The costs of diabetes mellitus and its complications in Germany].
    Hauner H
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S240-2. PubMed ID: 17139578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
    Ringborg A; Martinell M; Stålhammar J; Yin DD; Lindgren P
    Int J Clin Pract; 2008 May; 62(5):708-16. PubMed ID: 18355236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of health services in the Czech Republic.
    Stritecky R; Pirozek P; Dvorak P
    J Health Adm Educ; 1998; 16(2):157-63. PubMed ID: 10387231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical resources consumption of type 2 diabetics in France in 1998].
    Detournay B; Fagnani F; Pribil C; Eschwège E
    Diabetes Metab; 2000 May; 26(3):225-31. PubMed ID: 10880898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of medical care among type 2 diabetic patients with a co-morbid condition--hypertension in India.
    Tharkar S; Satyavani K; Viswanathan V
    Diabetes Res Clin Pract; 2009 Feb; 83(2):263-7. PubMed ID: 19118912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study.
    Schöffski O; Breitscheidel L; Benter U; Dippel FW; Müller M; Volk M; Pfohl M
    J Med Econ; 2008; 11(4):695-712. PubMed ID: 19450076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social costs of obesity in the Czech Republic.
    Landovská P; Karbanová M
    Eur J Health Econ; 2023 Nov; 24(8):1321-1341. PubMed ID: 36449132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia.
    Ali M; White J; Lee CH; Palmer JL; Smith-Palmer J; Fakhoury W; Valentine WJ
    J Med Econ; 2008; 11(4):651-70. PubMed ID: 19450074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost of medication in the Czech Republic--causes of growth in costs and solution proposals].
    Zigová Z
    Vnitr Lek; 2007 Jun; 53(6):760-74. PubMed ID: 17702137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of the care and treatment for people with Alzheimer's disease: the outlook for the Czech Republic.
    Marešová P; Zahálková V
    Neurol Sci; 2016 Dec; 37(12):1917-1922. PubMed ID: 27470305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In response to article on CODEIRE study.
    Smith SM; O'Dowd T
    Ir Med J; 2007 Feb; 100(2):378-9. PubMed ID: 17436462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Realistic possibilities of using data sources in quality assessment of care of patients with diabetes in the Czech Republic: National Diabetes Information System].
    Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S10-3. PubMed ID: 26652959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy].
    Vlcek J; Malý J; Dosedel M
    Vnitr Lek; 2009 Apr; 55(4):384-8. PubMed ID: 19449755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct medical cost of children and adolescents epilepsy at a university setting in Croatia.
    Prpić I; Boban M; Skarpa-Prpić I; Jurjević A; Babić T; Fiket D
    Coll Antropol; 2009 Jun; 33(2):503-8. PubMed ID: 19662770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.
    Owusu-Edusei K; Tejani MN; Gift TL; Kent CK; Tao G
    Sex Transm Dis; 2009 Jun; 36(6):395-9. PubMed ID: 19556934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.